Issue 94, 2022

A novel AIEgen photosensitizer with an elevated intersystem crossing rate for tumor precise imaging and therapy

Abstract

Herein, we have designed and synthesized a quinolinyl-AIE photosensitizer (TPE-4QL+) with an alternative elevated intersystem crossing (ISC) rate, which exhibits not only highly efficient photosensitivity but also high tumor cell specificity and an excellent mitochondrial targeting ability. In vitro experiments indicate that using TPE-4QL+ as a photosensitizer can induce a series of tumor cells to die with a low dose of radiation, but with no obvious toxicity to normal cells. The in vivo studies on a mouse model bearing a subcutaneous 4T1 xenograft also show that TPE-4QL+ can be used with high efficiency as a photosensitizer in PDT.

Graphical abstract: A novel AIEgen photosensitizer with an elevated intersystem crossing rate for tumor precise imaging and therapy

Supplementary files

Article information

Article type
Communication
Submitted
28 Sep 2022
Accepted
01 Nov 2022
First published
02 Nov 2022

Chem. Commun., 2022,58, 13143-13146

A novel AIEgen photosensitizer with an elevated intersystem crossing rate for tumor precise imaging and therapy

Y. Hu, S. Yin, Z. Li, W. Qi, Y. Chen and J. Li, Chem. Commun., 2022, 58, 13143 DOI: 10.1039/D2CC05313F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements